Oramed Pharmaceuticals In... (ORMP)
NASDAQ: ORMP
· Real-Time Price · USD
2.44
-0.07 (-2.93%)
At close: Oct 03, 2025, 3:59 PM
2.48
1.64%
After-hours: Oct 03, 2025, 07:11 PM EDT
13F Institute Ownership
Total Institutes of 46 in Oramed Pharmaceuticals reduced their positions with a decrease of 8 investors compared to the previous quarter. A reduction of 639.98K shares, as total invested capital declined by $588.53K with ownership percentage dropping from 19.00% to 17.44%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Bml Capital Management, LLC | 7.54% | 3.08M | +2.07% | 6.94M | 5.25% | Aug 11, 2025 |
| Murchinson Ltd. | 4.28% | 1.75M | -0.01% | 3.94M | 1.40% | Aug 14, 2025 |
| Boothbay Fund Management, LLC | 2.07% | 845.39K | -0.01% | 1.9M | 0.04% | Aug 14, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.